BFSI

Global Antiandrogen Monotherapy Market Report 2019, Competitive Landscape, Trends and Opportunities

  • MAI3294103
  • 120 Pages
  • October 2019
  • BFSI
Download Sample    Get Discount   
 
The Antiandrogen Monotherapy market has witnessed growth from USD XX million to USD XX million from 2014 to 2019. With the CAGR of X.X%, this market is estimated to reach USD XX million in 2026.

The report mainly studies the size, recent trends and development status of the Antiandrogen Monotherapy market, as well as investment opportunities, government policy, market dynamics (drivers, restraints, opportunities), supply chain and competitive landscape. Technological innovation and advancement will further optimize the performance of the product, making it more widely used in downstream applications. Moreover, Porter's Five Forces Analysis (potential entrants, suppliers, substitutes, buyers, industry competitors) provides crucial information for knowing the Antiandrogen Monotherapy market.

Major players in the global Antiandrogen Monotherapy market include:

F. Hoffmann-La Roche Ltd. (Switzerland)

AstraZeneca PLC (UK)

Indevus Pharmaceuticals Inc. (USA)

Medimmune, LLC (USA)

Abbott Laboratories (USA)

Immunomedics, Inc. (USA)

EUSA Pharma, (USA) Inc. (USA)

Takeda Pharmaceutical Company Limited (Japan)

Pfizer Inc. (USA)

Dendreon Corporation (USA)

OSI Pharmaceuticals, Inc. (USA)

Cell Genesys Inc. (USA)

Genentech Inc. (USA)

Bristol-Myers Squibb Company (USA)

Spectrum Pharmaceuticals, Inc. (USA)

Novartis AG (Switzerland)

Paladin Labs Inc. (Canada)

Progenics Pharmaceuticals, Inc. (USA)

ALZA Corporation (USA)

Sanofi-Aventis SA (France)

GlaxoSmithKline Plc (UK)

Amgen Inc. (USA)

On the basis of types, the Antiandrogen Monotherapy market is primarily split into:

Type 1

Type 2

Type 3

On the basis of applications, the market covers:

Application 1

Application 2

Application 3

Geographically, the report includes the research on production, consumption, revenue, market share and growth rate, and forecast (2014-2026) of the following regions:

United States

Europe (Germany, UK, France, Italy, Spain, Russia, Poland)

China

Japan

India

Southeast Asia (Malaysia, Singapore, Philippines, Indonesia, Thailand, Vietnam)

Central and South America (Brazil, Mexico, Colombia)

Middle East and Africa (Saudi Arabia, United Arab Emirates, Turkey, Egypt, South Africa, Nigeria)

Other Regions

Chapter 1 provides an overview of Antiandrogen Monotherapy market, containing global revenue, global production, sales, and CAGR. The forecast and analysis of Antiandrogen Monotherapy market by type, application, and region are also presented in this chapter.

Chapter 2 is about the market landscape and major players. It provides competitive situation and market concentration status along with the basic information of these players.

Chapter 3 provides a full-scale analysis of major players in Antiandrogen Monotherapy industry. The basic information, as well as the profiles, applications and specifications of products market performance along with Business Overview are offered.

Chapter 4 gives a worldwide view of Antiandrogen Monotherapy market. It includes production, market share revenue, price, and the growth rate by type.

Chapter 5 focuses on the application of Antiandrogen Monotherapy, by analyzing the consumption and its growth rate of each application.

Chapter 6 is about production, consumption, export, and import of Antiandrogen Monotherapy in each region.

Chapter 7 pays attention to the production, revenue, price and gross margin of Antiandrogen Monotherapy in markets of different regions. The analysis on production, revenue, price and gross margin of the global market is covered in this part.

Chapter 8 concentrates on manufacturing analysis, including key raw material analysis, cost structure analysis and process analysis, making up a comprehensive analysis of manufacturing cost.

Chapter 9 introduces the industrial chain of Antiandrogen Monotherapy. Industrial chain analysis, raw material sources and downstream buyers are analyzed in this chapter.

Chapter 10 provides clear insights into market dynamics.

Chapter 11 prospects the whole Antiandrogen Monotherapy market, including the global production and revenue forecast, regional forecast. It also foresees the Antiandrogen Monotherapy market by type and application.

Chapter 12 concludes the research findings and refines all the highlights of the study.

Chapter 13 introduces the research methodology and sources of research data for your understanding.

Years considered for this report:

Historical Years: 2014-2018

Base Year: 2019

Estimated Year: 2019

Forecast Period: 2019-2026

Table of Contents

1 Antiandrogen Monotherapy Market Overview

1.1 Product Overview and Scope of Antiandrogen Monotherapy

1.2 Antiandrogen Monotherapy Segment by Type

1.2.1 Global Antiandrogen Monotherapy Production and CAGR (%) Comparison by Type (2014-2026)

1.2.2 The Market Profile of Type 1

1.2.3 The Market Profile of Type 2

1.2.4 The Market Profile of Type 3

1.3 Global Antiandrogen Monotherapy Segment by Application

1.3.1 Antiandrogen Monotherapy Consumption (Sales) Comparison by Application (2014-2026)

1.3.2 The Market Profile of Application 1

1.3.3 The Market Profile of Application 2

1.3.4 The Market Profile of Application 3

1.4 Global Antiandrogen Monotherapy Market by Region (2014-2026)

1.4.1 Global Antiandrogen Monotherapy Market Size (Value) and CAGR (%) Comparison by Region (2014-2026)

1.4.2 United States Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.3 Europe Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.3.1 Germany Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.3.2 UK Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.3.3 France Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.3.4 Italy Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.3.5 Spain Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.3.6 Russia Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.3.7 Poland Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.4 China Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.5 Japan Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.6 India Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.7 Southeast Asia Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.7.1 Malaysia Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.7.2 Singapore Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.7.3 Philippines Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.7.4 Indonesia Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.7.5 Thailand Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.7.6 Vietnam Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.8 Central and South America Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.8.1 Brazil Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.8.2 Mexico Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.8.3 Colombia Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.9 Middle East and Africa Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.9.1 Saudi Arabia Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.9.2 United Arab Emirates Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.9.3 Turkey Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.9.4 Egypt Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.9.5 South Africa Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.4.9.6 Nigeria Antiandrogen Monotherapy Market Status and Prospect (2014-2026)

1.5 Global Market Size (Value) of Antiandrogen Monotherapy (2014-2026)

1.5.1 Global Antiandrogen Monotherapy Revenue Status and Outlook (2014-2026)

1.5.2 Global Antiandrogen Monotherapy Production Status and Outlook (2014-2026)

2 Global Antiandrogen Monotherapy Market Landscape by Player

2.1 Global Antiandrogen Monotherapy Production and Share by Player (2014-2019)

2.2 Global Antiandrogen Monotherapy Revenue and Market Share by Player (2014-2019)

2.3 Global Antiandrogen Monotherapy Average Price by Player (2014-2019)

2.4 Antiandrogen Monotherapy Manufacturing Base Distribution, Sales Area and Product Type by Player

2.5 Antiandrogen Monotherapy Market Competitive Situation and Trends

2.5.1 Antiandrogen Monotherapy Market Concentration Rate

2.5.2 Antiandrogen Monotherapy Market Share of Top 3 and Top 6 Players

2.5.3 Mergers & Acquisitions, Expansion

3 Players Profiles

3.1 F. Hoffmann-La Roche Ltd. (Switzerland)

3.1.1 F. Hoffmann-La Roche Ltd. (Switzerland) Basic Information, Manufacturing Base, Sales Area and Competitors

3.1.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.1.3 F. Hoffmann-La Roche Ltd. (Switzerland) Antiandrogen Monotherapy Market Performance (2014-2019)

3.1.4 F. Hoffmann-La Roche Ltd. (Switzerland) Business Overview

3.2 AstraZeneca PLC (UK)

3.2.1 AstraZeneca PLC (UK) Basic Information, Manufacturing Base, Sales Area and Competitors

3.2.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.2.3 AstraZeneca PLC (UK) Antiandrogen Monotherapy Market Performance (2014-2019)

3.2.4 AstraZeneca PLC (UK) Business Overview

3.3 Indevus Pharmaceuticals Inc. (USA)

3.3.1 Indevus Pharmaceuticals Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.3.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.3.3 Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.3.4 Indevus Pharmaceuticals Inc. (USA) Business Overview

3.4 Medimmune, LLC (USA)

3.4.1 Medimmune, LLC (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.4.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.4.3 Medimmune, LLC (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.4.4 Medimmune, LLC (USA) Business Overview

3.5 Abbott Laboratories (USA)

3.5.1 Abbott Laboratories (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.5.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.5.3 Abbott Laboratories (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.5.4 Abbott Laboratories (USA) Business Overview

3.6 Immunomedics, Inc. (USA)

3.6.1 Immunomedics, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.6.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.6.3 Immunomedics, Inc. (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.6.4 Immunomedics, Inc. (USA) Business Overview

3.7 EUSA Pharma, (USA) Inc. (USA)

3.7.1 EUSA Pharma, (USA) Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.7.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.7.3 EUSA Pharma, (USA) Inc. (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.7.4 EUSA Pharma, (USA) Inc. (USA) Business Overview

3.8 Takeda Pharmaceutical Company Limited (Japan)

3.8.1 Takeda Pharmaceutical Company Limited (Japan) Basic Information, Manufacturing Base, Sales Area and Competitors

3.8.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.8.3 Takeda Pharmaceutical Company Limited (Japan) Antiandrogen Monotherapy Market Performance (2014-2019)

3.8.4 Takeda Pharmaceutical Company Limited (Japan) Business Overview

3.9 Pfizer Inc. (USA)

3.9.1 Pfizer Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.9.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.9.3 Pfizer Inc. (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.9.4 Pfizer Inc. (USA) Business Overview

3.10 Dendreon Corporation (USA)

3.10.1 Dendreon Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.10.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.10.3 Dendreon Corporation (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.10.4 Dendreon Corporation (USA) Business Overview

3.11 OSI Pharmaceuticals, Inc. (USA)

3.11.1 OSI Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.11.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.11.3 OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.11.4 OSI Pharmaceuticals, Inc. (USA) Business Overview

3.12 Cell Genesys Inc. (USA)

3.12.1 Cell Genesys Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.12.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.12.3 Cell Genesys Inc. (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.12.4 Cell Genesys Inc. (USA) Business Overview

3.13 Genentech Inc. (USA)

3.13.1 Genentech Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.13.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.13.3 Genentech Inc. (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.13.4 Genentech Inc. (USA) Business Overview

3.14 Bristol-Myers Squibb Company (USA)

3.14.1 Bristol-Myers Squibb Company (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.14.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.14.3 Bristol-Myers Squibb Company (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.14.4 Bristol-Myers Squibb Company (USA) Business Overview

3.15 Spectrum Pharmaceuticals, Inc. (USA)

3.15.1 Spectrum Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.15.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.15.3 Spectrum Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.15.4 Spectrum Pharmaceuticals, Inc. (USA) Business Overview

3.16 Novartis AG (Switzerland)

3.16.1 Novartis AG (Switzerland) Basic Information, Manufacturing Base, Sales Area and Competitors

3.16.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.16.3 Novartis AG (Switzerland) Antiandrogen Monotherapy Market Performance (2014-2019)

3.16.4 Novartis AG (Switzerland) Business Overview

3.17 Paladin Labs Inc. (Canada)

3.17.1 Paladin Labs Inc. (Canada) Basic Information, Manufacturing Base, Sales Area and Competitors

3.17.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.17.3 Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Market Performance (2014-2019)

3.17.4 Paladin Labs Inc. (Canada) Business Overview

3.18 Progenics Pharmaceuticals, Inc. (USA)

3.18.1 Progenics Pharmaceuticals, Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.18.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.18.3 Progenics Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.18.4 Progenics Pharmaceuticals, Inc. (USA) Business Overview

3.19 ALZA Corporation (USA)

3.19.1 ALZA Corporation (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.19.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.19.3 ALZA Corporation (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.19.4 ALZA Corporation (USA) Business Overview

3.20 Sanofi-Aventis SA (France)

3.20.1 Sanofi-Aventis SA (France) Basic Information, Manufacturing Base, Sales Area and Competitors

3.20.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.20.3 Sanofi-Aventis SA (France) Antiandrogen Monotherapy Market Performance (2014-2019)

3.20.4 Sanofi-Aventis SA (France) Business Overview

3.21 GlaxoSmithKline Plc (UK)

3.21.1 GlaxoSmithKline Plc (UK) Basic Information, Manufacturing Base, Sales Area and Competitors

3.21.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.21.3 GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Market Performance (2014-2019)

3.21.4 GlaxoSmithKline Plc (UK) Business Overview

3.22 Amgen Inc. (USA)

3.22.1 Amgen Inc. (USA) Basic Information, Manufacturing Base, Sales Area and Competitors

3.22.2 Antiandrogen Monotherapy Product Profiles, Application and Specification

3.22.3 Amgen Inc. (USA) Antiandrogen Monotherapy Market Performance (2014-2019)

3.22.4 Amgen Inc. (USA) Business Overview

4 Global Antiandrogen Monotherapy Production, Revenue (Value), Price Trend by Type

4.1 Global Antiandrogen Monotherapy Production and Market Share by Type (2014-2019)

4.2 Global Antiandrogen Monotherapy Revenue and Market Share by Type (2014-2019)

4.3 Global Antiandrogen Monotherapy Price by Type (2014-2019)

4.4 Global Antiandrogen Monotherapy Production Growth Rate by Type (2014-2019)

4.4.1 Global Antiandrogen Monotherapy Production Growth Rate of Type 1 (2014-2019)

4.4.2 Global Antiandrogen Monotherapy Production Growth Rate of Type 2 (2014-2019)

4.4.3 Global Antiandrogen Monotherapy Production Growth Rate of Type 3 (2014-2019)

5 Global Antiandrogen Monotherapy Market Analysis by Application

5.1 Global Antiandrogen Monotherapy Consumption and Market Share by Application (2014-2019)

5.2 Global Antiandrogen Monotherapy Consumption Growth Rate by Application (2014-2019)

5.2.1 Global Antiandrogen Monotherapy Consumption Growth Rate of Application 1 (2014-2019)

5.2.2 Global Antiandrogen Monotherapy Consumption Growth Rate of Application 2 (2014-2019)

5.2.3 Global Antiandrogen Monotherapy Consumption Growth Rate of Application 3 (2014-2019)

6 Global Antiandrogen Monotherapy Production, Consumption, Export, Import by Region (2014-2019)

6.1 Global Antiandrogen Monotherapy Consumption by Region (2014-2019)

6.2 United States Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

6.3 Europe Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

6.4 China Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

6.5 Japan Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

6.6 India Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

6.7 Southeast Asia Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

6.8 Central and South America Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

6.9 Middle East and Africa Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

7 Global Antiandrogen Monotherapy Production, Revenue (Value) by Region (2014-2019)

7.1 Global Antiandrogen Monotherapy Production and Market Share by Region (2014-2019)

7.2 Global Antiandrogen Monotherapy Revenue (Value) and Market Share by Region (2014-2019)

7.3 Global Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

7.4 United States Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

7.5 Europe Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

7.6 China Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

7.7 Japan Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

7.8 India Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

7.9 Southeast Asia Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

7.10 Central and South America Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

7.11 Middle East and Africa Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

8 Antiandrogen Monotherapy Manufacturing Analysis

8.1 Antiandrogen Monotherapy Key Raw Materials Analysis

8.1.1 Key Raw Materials Introduction

8.1.2 Price Trend of Key Raw Materials

8.1.3 Key Suppliers of Raw Materials

8.1.4 Market Concentration Rate of Raw Materials

8.2 Manufacturing Cost Analysis

8.2.1 Labor Cost Analysis

8.2.2 Manufacturing Cost Structure Analysis

8.3 Manufacturing Process Analysis of Antiandrogen Monotherapy

9 Industrial Chain, Sourcing Strategy and Downstream Buyers

9.1 Antiandrogen Monotherapy Industrial Chain Analysis

9.2 Raw Materials Sources of Antiandrogen Monotherapy Major Players in 2018

9.3 Downstream Buyers

10 Market Dynamics

10.1 Drivers

10.2 Restraints

10.3 Opportunities

10.3.1 Advances in Innovation and Technology for Antiandrogen Monotherapy

10.3.2 Increased Demand in Emerging Markets

10.4 Challenges

10.4.1 The Performance of Alternative Product Type is Getting Better and Better

10.4.2 Price Variance Caused by Fluctuations in Raw Material Prices

10.5 Porter’s Five Forces Analysis

10.5.1 Threat of New Entrants

10.5.2 Threat of Substitutes

10.5.3 Bargaining Power of Suppliers

10.5.4 Bargaining Power of Buyers

10.5.5 Intensity of Competitive Rivalry

11 Global Antiandrogen Monotherapy Market Forecast (2019-2026)

11.1 Global Antiandrogen Monotherapy Production, Revenue Forecast (2019-2026)

11.1.1 Global Antiandrogen Monotherapy Production and Growth Rate Forecast (2019-2026)

11.1.2 Global Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2019-2026)

11.1.3 Global Antiandrogen Monotherapy Price and Trend Forecast (2019-2026)

11.2 Global Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast by Region (2019-2026)

11.2.1 United States Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

11.2.2 Europe Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

11.2.3 China Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

11.2.4 Japan Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

11.2.5 India Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

11.2.6 Southeast Asia Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

11.2.7 Central and South America Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

11.2.8 Middle East and Africa Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

11.3 Global Antiandrogen Monotherapy Production, Revenue and Price Forecast by Type (2019-2026)

11.4 Global Antiandrogen Monotherapy Consumption Forecast by Application (2019-2026)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology

13.2 Research Data Source

List of Tables and Figures

Figure Antiandrogen Monotherapy Product Picture

Table Global Antiandrogen Monotherapy Production and CAGR (%) Comparison by Type

Table Profile of Type 1

Table Profile of Type 2

Table Profile of Type 3

Table Antiandrogen Monotherapy Consumption (Sales) Comparison by Application (2014-2026)

Table Profile of Application 1

Table Profile of Application 2

Table Profile of Application 3

Figure Global Antiandrogen Monotherapy Market Size (Value) and CAGR (%) (2014-2026)

Figure United States Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Europe Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Germany Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure UK Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure France Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Italy Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Spain Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Russia Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Poland Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure China Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Japan Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure India Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Southeast Asia Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Malaysia Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Singapore Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Philippines Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Indonesia Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Thailand Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Vietnam Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Central and South America Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Brazil Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Mexico Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Colombia Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Middle East and Africa Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Saudi Arabia Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure United Arab Emirates Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Turkey Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Egypt Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure South Africa Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Nigeria Antiandrogen Monotherapy Revenue and Growth Rate (2014-2026)

Figure Global Antiandrogen Monotherapy Production Status and Outlook (2014-2026)

Table Global Antiandrogen Monotherapy Production by Player (2014-2019)

Table Global Antiandrogen Monotherapy Production Share by Player (2014-2019)

Figure Global Antiandrogen Monotherapy Production Share by Player in 2018

Table Antiandrogen Monotherapy Revenue by Player (2014-2019)

Table Antiandrogen Monotherapy Revenue Market Share by Player (2014-2019)

Table Antiandrogen Monotherapy Price by Player (2014-2019)

Table Antiandrogen Monotherapy Manufacturing Base Distribution and Sales Area by Player

Table Antiandrogen Monotherapy Product Type by Player

Table Mergers & Acquisitions, Expansion Plans

Table F. Hoffmann-La Roche Ltd. (Switzerland) Profile

Table F. Hoffmann-La Roche Ltd. (Switzerland) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table AstraZeneca PLC (UK) Profile

Table AstraZeneca PLC (UK) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Indevus Pharmaceuticals Inc. (USA) Profile

Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Medimmune, LLC (USA) Profile

Table Medimmune, LLC (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Abbott Laboratories (USA) Profile

Table Abbott Laboratories (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Immunomedics, Inc. (USA) Profile

Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table EUSA Pharma, (USA) Inc. (USA) Profile

Table EUSA Pharma, (USA) Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Takeda Pharmaceutical Company Limited (Japan) Profile

Table Takeda Pharmaceutical Company Limited (Japan) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Pfizer Inc. (USA) Profile

Table Pfizer Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Dendreon Corporation (USA) Profile

Table Dendreon Corporation (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table OSI Pharmaceuticals, Inc. (USA) Profile

Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Cell Genesys Inc. (USA) Profile

Table Cell Genesys Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Genentech Inc. (USA) Profile

Table Genentech Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Bristol-Myers Squibb Company (USA) Profile

Table Bristol-Myers Squibb Company (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Spectrum Pharmaceuticals, Inc. (USA) Profile

Table Spectrum Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Novartis AG (Switzerland) Profile

Table Novartis AG (Switzerland) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Paladin Labs Inc. (Canada) Profile

Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Progenics Pharmaceuticals, Inc. (USA) Profile

Table Progenics Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table ALZA Corporation (USA) Profile

Table ALZA Corporation (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Sanofi-Aventis SA (France) Profile

Table Sanofi-Aventis SA (France) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table GlaxoSmithKline Plc (UK) Profile

Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Amgen Inc. (USA) Profile

Table Amgen Inc. (USA) Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Global Antiandrogen Monotherapy Production by Type (2014-2019)

Table Global Antiandrogen Monotherapy Production Market Share by Type (2014-2019)

Figure Global Antiandrogen Monotherapy Production Market Share by Type in 2018

Table Global Antiandrogen Monotherapy Revenue by Type (2014-2019)

Table Global Antiandrogen Monotherapy Revenue Market Share by Type (2014-2019)

Figure Global Antiandrogen Monotherapy Revenue Market Share by Type in 2018

Table Antiandrogen Monotherapy Price by Type (2014-2019)

Figure Global Antiandrogen Monotherapy Production Growth Rate of Type 1 (2014-2019)

Figure Global Antiandrogen Monotherapy Production Growth Rate of Type 2 (2014-2019)

Figure Global Antiandrogen Monotherapy Production Growth Rate of Type 3 (2014-2019)

Table Global Antiandrogen Monotherapy Consumption by Application (2014-2019)

Table Global Antiandrogen Monotherapy Consumption Market Share by Application (2014-2019)

Table Global Antiandrogen Monotherapy Consumption of Application 1 (2014-2019)

Table Global Antiandrogen Monotherapy Consumption of Application 2 (2014-2019)

Table Global Antiandrogen Monotherapy Consumption of Application 3 (2014-2019)

Table Global Antiandrogen Monotherapy Consumption by Region (2014-2019)

Table Global Antiandrogen Monotherapy Consumption Market Share by Region (2014-2019)

Table United States Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

Table Europe Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

Table China Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

Table Japan Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

Table India Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

Table Southeast Asia Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

Table Central and South America Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

Table Middle East and Africa Antiandrogen Monotherapy Production, Consumption, Export, Import (2014-2019)

Table Global Antiandrogen Monotherapy Production by Region (2014-2019)

Table Global Antiandrogen Monotherapy Production Market Share by Region (2014-2019)

Figure Global Antiandrogen Monotherapy Production Market Share by Region (2014-2019)

Figure Global Antiandrogen Monotherapy Production Market Share by Region in 2018

Table Global Antiandrogen Monotherapy Revenue by Region (2014-2019)

Table Global Antiandrogen Monotherapy Revenue Market Share by Region (2014-2019)

Figure Global Antiandrogen Monotherapy Revenue Market Share by Region (2014-2019)

Figure Global Antiandrogen Monotherapy Revenue Market Share by Region in 2018

Table Global Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table United States Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Europe Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table China Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Japan Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table India Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Southeast Asia Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Central and South America Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Middle East and Africa Antiandrogen Monotherapy Production, Revenue, Price and Gross Margin (2014-2019)

Table Key Raw Materials Introduction of Antiandrogen Monotherapy

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Market Concentration Rate of Raw Materials

Figure Manufacturing Cost Structure Analysis

Figure Manufacturing Process Analysis of Antiandrogen Monotherapy

Figure Antiandrogen Monotherapy Industrial Chain Analysis

Table Raw Materials Sources of Antiandrogen Monotherapy Major Players in 2018

Table Downstream Buyers

Figure Global Antiandrogen Monotherapy Production and Growth Rate Forecast (2019-2026)

Figure Global Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2019-2026)

Figure Global Antiandrogen Monotherapy Price and Trend Forecast (2019-2026)

Table United States Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

Table Europe Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

Table China Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

Table Japan Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

Table India Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

Table Southeast Asia Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

Table Middle East and Africa Antiandrogen Monotherapy Production, Consumption, Export and Import Forecast (2019-2026)

Table Global Antiandrogen Monotherapy Market Production Forecast, by Type

Table Global Antiandrogen Monotherapy Production Volume Market Share Forecast, by Type

Table Global Antiandrogen Monotherapy Market Revenue Forecast, by Type

Table Global Antiandrogen Monotherapy Revenue Market Share Forecast, by Type

Table Global Antiandrogen Monotherapy Price Forecast, by Type

Table Global Antiandrogen Monotherapy Market Production Forecast, by Application

Table Global Antiandrogen Monotherapy Production Volume Market Share Forecast, by Application

Table Global Antiandrogen Monotherapy Market Revenue Forecast, by Application

Table Global Antiandrogen Monotherapy Revenue Market Share Forecast, by Application

Table Global Antiandrogen Monotherapy Price Forecast, by Application

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Global Online banking Market - Size, Share, Trends and Forecast 2012 - 2020

Online banking or internet banking is a service provided by retail bank, virtual bank (neo banks) or credit unions. Online banking provides the customers with a secure website through which they can conduct financial transactions. Recent trends show that, customers are keenly adopting on...

  • Publish Date: July 31, 2017
  • $5370
Asia-Pacific ATM Market - Opportunities and Forecast, 2014 - 2020

ATMs have evolved from just cash dispensing machines to multifunctional equipment that provide not only cash withdrawal facilities but offer currency conversions facilities, account information, deposits, transfers, bill payment, cash recycling among other services. The Asia-Pacific region is becoming increasingly characterized by technology-facilitated transactions. ...

  • Publish Date: March 1, 2016
  • $3390
Global P2P (Person-To-Person Lending) Industry 2015 Deep Market Research Report

The Global P2P Industry 2016 Deep Market Research Report is a professional and in-depth study on the current state of the P2P industry. The report provides a basic overview of the industry including definitions and classifications. The P2P market analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status. ...

  • Publish Date: January 15, 2016
  • $2800